Literature DB >> 2738704

The molecular structure of indium-DTPA.

H R Maecke1, A Riesen, W Ritter.   

Abstract

The x-ray structural characterization of Na2In(DTPA).7 H2O is described. The structure is notable for two reasons. It is the first In3+-complex with relevance to antibody attachment to be structurally characterized. Surprisingly, the complex has coordination number eight and is the first monomeric In3+-complex with such a high coordination number. The potentially octadentate ligand binds through three amino groups and five deprotonated carboxylate groups to the metal ion. The ligand atoms surround the central indium atom in a slightly distorted Archimedian antiprismatic configuration. High resolution nuclear magnetic resonance studies in solution show that this high coordination number also pertains in aqueous medium. Consequently, one may conclude that octadentate ligands are optimal for the thermodynamic and kinetic stabilization of In3+ in living systems. It is also indicated that bifunctional diethylenetriaminepentaacetic acid (DTPA) is superior to amide bound (= sevendentate) DTPA in antibody labeling.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2738704

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles.

Authors:  A A Abdelmoez; G C Thurner; E A Wallnöfer; N Klammsteiner; C Kremser; H Talasz; M Mrakovcic; E Fröhlich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-07-14       Impact factor: 4.304

Review 3.  Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

Authors:  Shuang Liu
Journal:  Adv Drug Deliv Rev       Date:  2008-04-23       Impact factor: 15.470

4.  Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.

Authors:  Joeri Kuil; Tessa Buckle; Hushan Yuan; Nynke S van den Berg; Shinya Oishi; Nobutaka Fujii; Lee Josephson; Fijs W B van Leeuwen
Journal:  Bioconjug Chem       Date:  2011-04-19       Impact factor: 4.774

5.  Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.

Authors:  A Chetanneau; R P Baum; P A Lehur; J C Liehn; A C Perkins; R Bares; P Bourguet; J Y Herry; J C Saccavini; J F Chatal
Journal:  Eur J Nucl Med       Date:  1990

6.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

7.  H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.

Authors:  Gwendolyn A Bailey; Eric W Price; Brian M Zeglis; Cara L Ferreira; Eszter Boros; Michael J Lacasse; Brian O Patrick; Jason S Lewis; Michael J Adam; Chris Orvig
Journal:  Inorg Chem       Date:  2012-10-29       Impact factor: 5.165

8.  A drug-repositioning screening identifies pentetic acid as a potential therapeutic agent for suppressing the elastase-mediated virulence of Pseudomonas aeruginosa.

Authors:  Mia Gi; Junhui Jeong; Keehoon Lee; Kang-Mu Lee; Masanori Toyofuku; Dong Eun Yong; Sang Sun Yoon; Jae Young Choi
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

9.  Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA).

Authors:  L Camera; S Kinuya; K Garmestani; M W Brechbiel; C Wu; L H Pai; T J McMurry; O A Gansow; I Pastan; C H Paik
Journal:  Eur J Nucl Med       Date:  1994-07

10.  A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma.

Authors:  D R Bard; C G Knight; D P Page-Thomas
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.